HEALTHCARE
Global Pharmaceutical Contract Manufacturing Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Pharmaceutical Contract Manufacturing Market, By Service (Drug Development Services, Pharmaceutical Manufacturing Services, Biologics Manufacturing Services, Packaging and Labelling Services, Fill-Finish Services, and Others), End Use (Big Pharmaceutical Companies, Small and Mid-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, and Others), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global Pharmaceutical Contract Manufacturing market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.
The global Pharmaceutical Contract Manufacturing Market involves outsourcing of pharmaceutical production and related services to a specialized external company, known as a contract manufacturer or Contract Manufacturing Organization (CMO). This practice allows pharmaceutical companies to leverage external expertise and resources for the production of drugs and related products.
The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
- Rising demand for biologics
- Shortened drug development cycles
RESTRAINTS
- Regulatory compliance
- Dependency on external partners
OPPORTUNITIES
- Growth in emerging markets
- End-to-end service offerings
CHALLENGES
- Quality management
- Increasing complexity of drug products
SEGMENTATION
- Service
- Drug Development Services
- Pharmaceutical Manufacturing Services
- Pharmaceutical API Manufacturing Services
- Pharmaceutical FDF Manufacturing Services
- Biologics Manufacturing Services
- Biologics API Manufacturing Services
- Biologics FDF Manufacturing Services
- Packaging and Labelling Services
- Fill-Finish Services
- Others
- End Use
- Big Pharmaceutical Companies
- Small and Mid-Sized Pharmaceutical Companies
- Generic Pharmaceutical Companies
- Others
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Thermo Fisher Scientific, Inc.
- Lonza Group
- WuXi Apptec
- AbbVie, Inc.
- Samsung Biologics
- Evonik Industries AG
- FUJIFILM Holding Corporation
- Siegfried Holding AG
- Almac Group
- Vetter Pharma
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Pharmaceutical Contract Manufacturing Market, by Service
- 3.2 Global Pharmaceutical Contract Manufacturing Market, by End Use
- 3.3 Global Pharmaceutical Contract Manufacturing Market, by Geography
- 3.4 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Digitalization
- 5.1.2 Tailored treatments
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Rising demand for biologics
- 5.2.2 Shortened drug development cycles
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 Regulatory compliance
- 5.3.2 Dependency on external partners
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Growth in emerging markets
- 5.4.2 End-to-end service offerings
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Quality management
- 5.5.2 Increasing complexity of drug products
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE
- 6.1 Service Summary
- 6.2 Market Attractive Index
- 6.3 Global Pharmaceutical Contract Manufacturing Market, by Service (2019-2032)
- SECTION 7 - GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USE
- 7.1 End Use Summary
- 7.2 Market Attractive Index
- 7.3 Global Pharmaceutical Contract Manufacturing Market, by End Use (2019-2032)
- SECTION 8 - GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY GEOGRAPHY
- 8.1 Regional Summary
- 8.2 Market Attractive Index
- 8.3 Global Pharmaceutical Contract Manufacturing Market, by Geography (2019-2032)
- SECTION 9 - NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
- 9.1 North America Summary
- 9.2 Market Attractive Index
- 9.3 North America Pharmaceutical Contract Manufacturing Market, by Service (2019-2032)
- 9.4 North America Pharmaceutical Contract Manufacturing Market, by End Use (2019-2032)
- 9.5 North America Pharmaceutical Contract Manufacturing Market, by Country (2019-2032)
- 9.5.1 U.S.
- 9.5.2 Canada
- 9.5.3 Mexico
- 9.5.4 Rest of North America
- SECTION 10 - EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
- 10.1 Europe Summary
- 10.2 Market Attractive Index
- 10.3 Europe Pharmaceutical Contract Manufacturing Market, by Service (2019-2032)
- 10.4 Europe Pharmaceutical Contract Manufacturing Market, by End Use (2019-2032)
- 10.5 Europe Pharmaceutical Contract Manufacturing Market, by Country (2019-2032)
- 10.5.1 Germany
- 10.5.2 U.K.
- 10.5.3 France
- 10.5.4 Italy
- 10.5.5 Spain
- 10.5.6 Russia
- 10.5.7 The Netherlands
- 10.5.8 Belgium
- 10.5.9 Turkey
- 10.5.10 Rest of Europe
- SECTION 11 - ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
- 11.1 Asia-Pacific Summary
- 11.2 Market Attractive Index
- 11.3 Asia-Pacific Pharmaceutical Contract Manufacturing Market, by Service (2019-2032)
- 11.4 Asia-Pacific Pharmaceutical Contract Manufacturing Market, by End Use (2019-2032)
- 11.5 Asia-Pacific Pharmaceutical Contract Manufacturing Market, by Country (2019-2032)
- 11.5.1 China
- 11.5.2 India
- 11.5.3 Japan
- 11.5.4 South Korea
- 11.5.5 Singapore
- 11.5.6 Malaysia
- 11.5.7 Australia
- 11.5.8 Thailand
- 11.5.9 Philippines
- 11.5.10 Rest of Asia-Pacific
- SECTION 12 - SOUTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
- 12.1 South America Summary
- 12.2 Market Attractive Index
- 12.3 South America Pharmaceutical Contract Manufacturing Market, by Service (2019-2032)
- 12.4 South America Pharmaceutical Contract Manufacturing Market, by End Use (2019-2032)
- 12.5 South America Pharmaceutical Contract Manufacturing Market, by Country (2019-2032)
- 12.5.1 Brazil
- 12.5.2 Argentina
- 12.5.3 Chile
- 12.5.4 Colombia
- 12.5.5 Rest of South America
- SECTION 13 - MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
- 13.1 Middle East and Africa Summary
- 13.2 Market Attractive Index
- 13.3 Middle East and Africa Pharmaceutical Contract Manufacturing Market, by Service (2019-2032)
- 13.4 Middle East and Africa Pharmaceutical Contract Manufacturing Market, by End Use (2019-2032)
- 13.5 Middle East and Africa Pharmaceutical Contract Manufacturing Market, by Country (2019-2032)
- 13.5.1 Kingdom of Saudi Arabia
- 13.5.2 South Africa
- 13.5.3 U.A.E.
- 13.5.4 Egypt
- 13.5.5 Rest of Middle East and Africa
- SECTION 14 - COMPANY SHARE ANALYSIS
- 14.1 Global Pharmaceutical Contract Manufacturing Market, Company Share Analysis
- 14.2 North America Pharmaceutical Contract Manufacturing Market, Company Share Analysis
- 14.3 Europe Pharmaceutical Contract Manufacturing Market, Company Share Analysis
- 14.4 Asia-Pacific Pharmaceutical Contract Manufacturing Market, Company Share Analysis
- SECTION 15 - COMPANY PROFILES
- 15.1 Thermo Fisher Scientific, Inc.
- 15.1.1 Company Snapshot
- 15.1.2 Financial Overview
- 15.1.3 Product Portfolio
- 15.1.4 Recent Developments
- 15.2 Lonza Group
- 15.2.1 Company Snapshot
- 15.2.2 Financial Overview
- 15.2.3 Product Portfolio
- 15.2.4 Recent Developments
- 15.3 WuXi Apptec
- 15.3.1 Company Snapshot
- 15.3.2 Financial Overview
- 15.3.3 Product Portfolio
- 15.3.4 Recent Developments
- 15.4 AbbVie, Inc.
- 15.4.1 Company Snapshot
- 15.4.2 Financial Overview
- 15.4.3 Product Portfolio
- 15.4.4 Recent Developments
- 15.5 Samsung Biologics
- 15.5.1 Company Snapshot
- 15.5.2 Financial Overview
- 15.5.3 Product Portfolio
- 15.5.4 Recent Developments
- 15.6 Evonik Industries AG
- 15.6.1 Company Snapshot
- 15.6.2 Financial Overview
- 15.6.3 Product Portfolio
- 15.6.4 Recent Developments
- 15.7 FUJIFILM Holding Corporation
- 15.7.1 Company Snapshot
- 15.7.2 Financial Overview
- 15.7.3 Product Portfolio
- 15.7.4 Recent Developments
- 15.8 Siegfried Holding AG
- 15.8.1 Company Snapshot
- 15.8.2 Financial Overview
- 15.8.3 Product Portfolio
- 15.8.4 Recent Developments
- 15.9 Almac Group
- 15.9.1 Company Snapshot
- 15.9.2 Financial Overview
- 15.9.3 Product Portfolio
- 15.9.4 Recent Developments
- 15.10 Vetter Pharma
- 15.10.1 Company Snapshot
- 15.10.2 Financial Overview
- 15.10.3 Product Portfolio
- 15.10.4 Recent Developments
- SECTION 16 - RELATED REPORTS
- SECTION 17 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.